Delix Therapeutics

Drug Discovery · Bedford, MA · Founded 2019 · Privately Held (backing)

Developer of neuroscience therapeutics designed to address mental health and central nervous system conditions. Delix Therapeutics is based in Bedford, MA and was founded in 2019. It was valued at $156 million at a grant in Jun 2024, the last priced event on record. It has raised $109 million across 1 recorded round; the latest was a $70 million Series A in Sep 2021.

PMV mark · valuation
$156.2M
Oct 2026
Priced at
a grant
Jun 2024
Total raised
$108.5M
Last round
Early Stage VC (Series A)
Sep 2021
How much has Delix Therapeutics raised?
$108.5Macross 1 recorded rounds · Sep 2021 – Sep 2021

Most recently, Delix Therapeutics raised $70.0M in its Early Stage VC (Series A) (Sep 2021).

Free account
More of Delix Therapeutics with a free account
  • ·The complete investor list: 40 names
  • ·Watch Delix Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Delix Therapeutics round by round

1 rounds
Sep 2021Early Stage VC (Series A)$70.0M▮
+ 1 more investors · free account

How much has Delix Therapeutics raised?

Delix Therapeutics has raised $109 million in total; 1 of its rounds is on record. The largest on record was a $70 million Series A in Sep 2021.

Delix Therapeutics investors

40 investors are on record for Delix Therapeutics, including Gaingels, RA Capital Management, Calm Ventures and United States Department of War. By type, the record holds 6 venture capital firms, 3 family offices and 1 asset manager. The Series A in Sep 2021 drew 17 investors.

For fundraisers
Raising for a company like Delix Therapeutics?

40 investors have backed Delix Therapeutics — start your target list with the firms already writing checks in drug discovery.

See all 40 investors →

Frequently asked about Delix Therapeutics

How much has Delix Therapeutics raised?
Delix Therapeutics has raised $108.5M in total across 1 recorded funding rounds.
When was Delix Therapeutics's last funding round?
Delix Therapeutics's most recent recorded round was Early Stage VC (Series A) in Sep 2021, raising $70.0M.